Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2012

Apr 2, 2012

30681_dirs_2012-04-02_ba3987d6-df3a-4aa1-9394-d78288c18c17.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-03-29

Reporting Person: ANDERSON DAVID L (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-29 Common Stock X 52301.0000 $2.9600 Acquired 394349.0000 Indirect
2012-03-29 Common Stock X 538.0000 $2.9600 Acquired 267288.0000 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-29 Common Stock Warrant $4.0500 P 52301.0000 Acquired 2015-03-29 Common Stock (52301.0000) Indirect
2012-03-29 Common Stock Warrant $2.9600 X 52301.0000 Disposed 2013-04-21 Common Stock (52301.0000) Indirect
2012-03-29 Common Stock Warrant $4.0500 P 538.0000 Acquired 2015-03-29 Common Stock (538.0000) Indirect
2012-03-29 Common Stock Warrant $2.9600 X 538.0000 Disposed 2013-04-21 Common Stock (538.0000) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 327603.0000 Indirect
Common Stock 11136.0000 Indirect

Footnotes

F1: Issuance of common stock upon exercise of warrants in accordance with the Warrant Purchase Agreement dated as of April 21, 2010.

F2: Shares held by SHV Profit Sharing Plan, a retirement trust, for the benefit of the reporting person.

F3: Shares held by a trust of which the reporting person is the trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

F4: Shares held by a limited partnership of which the reporting person is the trustee of a trust which is the General Partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F5: Acquired from the issuer pursuant to a Warrant Purchase Agreement dated March 25, 2012, whereby purchase of the new warrants was conditioned upon the exercise of warrants that had been issued on April 21, 2010 (see also Footnote #1 above).